Home / Recalls / HOSPIRA INC, LAKE FOREST / D-0906-2018

D-0906-2018 Class I Terminated

Recalled by HOSPIRA INC, LAKE FOREST — LAKE FOREST, IL

FDA drug recall D-0906-2018 was initiated by HOSPIRA INC, LAKE FOREST on Jun 4, 2018 and is designated Class I. Reason for recall: Presence of Particulate Matter; Potential for particulate matter on the syringe plunger. The recall status is terminated (terminated Mar 27, 2020). Affected quantity: 164,860 syringes.

Recall details

Product Type: Drugs
Report Date: Jun 13, 2018
Initiation Date: Jun 4, 2018
Termination Date: Mar 27, 2020
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 164,860 syringes

Product description

Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL

Reason for recall

Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.

Distribution pattern

Nationwide in the U.S., Puerto Rico, and Guam

Code information

72680LL, Exp. 1DEC2018 (NDC 0409-1782-03); 76510LL, Exp. 1APR2019 (NDC 0409-1782-69)

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0906-2018
openFDA file date: Nov 10, 2026
Loaded by RegDataLab: Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.